Therapeutic agent for coronavirus comprising Elaeocarpus sylvestris extract as effective component
KR20200058338A
Composition for prevention or treatment of retinal diseases comprising extract of Centella asiatica
KR102187335B1
Composition for improving premenstrual syndrome symptom comprising compounds isolated from Hordeum vulgare extract
KR20200107744A
Composition for prevention or treatment of retinal diseases comprising compounds isolated from Centella asiatica extract
KR20200103518A
Composition for improving premenstrual syndrome symptom comprising compounds isolated from Chrysanthemum zawadskii extract
WO2021045242A2
Composition for ameliorating premenstrual syndrome symptoms, including chrysanthemum sibiricum extract
KR20200071380A
Composition for improving premenstrual syndrome symptom comprising extract of Aucklandiae radix
KR20200042618A
Composition for prevention or treatment of retinal diseases comprising extract of Centella asiatica
KR20190105971A
Composition for improving premenstrual syndrome symptom comprising extract of Chrysanthemum zawadskii
WO2019168222A1
Culture medium composition for culturing of anti-cancer activated lymphocytes derived from peripheral blood mononuclear cells and method for culturing anti-cancer activated lymphocytes using same
KR101899122B1
Pharmaceutical composition for preventing or treating hepatitis C virus infectious disease
KR101833332B1
n-Hexane fractions of Morning glory seeds for nephroprotection and treating acute renal failure
KR20180088537A
Composition of Extracts and Fractions of Prunus mume Leaves having blood glucose control activity and/or insulin resistance
KR101834872B1
Pharmaceutical composition for prevention or treatment of alpha-type herpes virus infection comprising the extract of Elaeocarpus sylvestris or fraction thereof as an active ingredient
KR20180026905A
A medium compostion for lymphocyte derived from peripheral blood mononuclear cells having anticancer activity, and cultivation method using the same
